Ischemia-Modified Albumin as a New Biomarker in Predicting Oxidative Stress in Alopecia Areata

    January 2019 in “ Turkish journal of medical sciences ”
    Hatice Ataş, Müzeyyen Gönül, Yasin Öztürk, Mustafa Kavutçu
    TLDR Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.
    The study investigated ischemic modified albumin (IMA) as a biomarker for oxidative stress in alopecia areata (AA) by comparing IMA levels in AA patients and healthy controls. Results from multiple studies consistently showed higher IMA levels in AA patients, indicating significant oxidative stress. The findings suggested that IMA could be a reliable biomarker for assessing oxidative stress in AA, with high sensitivity and specificity, and highlighted the potential benefits of antioxidant prophylaxis in managing the condition. However, the study noted limitations such as small sample sizes and the need for further research.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 7 results

      community Atherosclerosis as cause of balding and treatment

      in Treatment  61 upvotes 1 year ago
      Hair loss may be caused by calcification of capillaries in the scalp, restricting blood flow to hair follicles. A daily treatment regimen including high doses of Vitamins D and K, Magnesium, and Nattokinase could potentially decalcify these capillaries, improving blood flow and hair growth. However, some users warn against excessive Vitamin D intake and emphasize the need for medical consultation.

      community Ru58841 ruined my life. Here’s why.

      in Product  128 upvotes 2 years ago
      User experienced shortness of breath, high blood pressure, red eyes, and eye floaters after using RU58841 for hair loss. They warn others to avoid RU58841 and stick to finasteride, minoxidil, and dutasteride.

      community Pyrilutamide Phase 3 on its way

      in Treatment  129 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Is itching related to hair loss?

      in Treatment  54 upvotes 2 years ago
      Hair loss, which is sometimes accompanied by itching. Treatments discussed include Minoxidil, finasteride, RU58841 and ketocazole shampoo.

    Related Research

    2 / 2 results